Association between TGFB1 915G/C polymorphism and susceptibility to chronic hepatitis C virus infection: A meta-analysis
- PMID: 24649103
- PMCID: PMC3917742
- DOI: 10.3892/br.2014.230
Association between TGFB1 915G/C polymorphism and susceptibility to chronic hepatitis C virus infection: A meta-analysis
Abstract
The human transforming growth factor-β1 (TGF-β1) gene, namely TGFB1, contains several single-nucleotide polymorphisms (SNPs) and some of the polymorphic variants were shown to affect the TGF-β1 protein levels. A number of studies reported the association between 915G/C polymorphism and susceptibility to chronic hepatitis C virus (HCV) infection. However, the results were inconsistent. This meta-analysis was conducted to assess the association of TGFB1 915G/C polymorphism with susceptibility to chronic HCV infection. PubMed, ISI Web of Knowledge, ScienceDirect and Google Scholar databases were systematically searched up to August, 2013 to identify relevant studies. The pooled odds ratios (ORs) with their corresponding 95% confidence intervals (95% CIs) were calculated in 5 genetic comparison models (C vs. G, CC vs. GG, GC vs. GG, CC vs. GG+GC and CC+GC vs. GG). The Galbraith plot and subgroup analyses based on ethnicity, genotyping methods, sample size and fibrosis were performed to investigate possible sources of heterogeneity. A sensitivity analysis and assessment of publication bias were also conducted. Finally, 8 eligible case-control studies on TGFB1 915G/C polymorphism, including a total of 910 cases and 632 controls, were included in this meta-analysis. Overall, there was no evidence of any gene-disease association obtained from the subgroup analyses. Therefore, this meta-analysis demonstrated that there is no association between TGFB1 915G/C polymorphisms and susceptibility to chronic HCV infection.
Keywords: 915G/C; hepatitis C virus; meta-analysis; polymorphism; transforming growth factor β1.
Figures



Similar articles
-
Transforming growth factor-β1 gene +869T/C, but not +915G/C polymorphism is associated with essential hypertension in a Chinese patient cohort.Mol Biol Rep. 2012 May;39(5):6107-12. doi: 10.1007/s11033-011-1427-5. Epub 2012 Jan 1. Mol Biol Rep. 2012. PMID: 22209986
-
Association of TGF-β1 -509C/T, +869T/C, and +915G/C polymorphisms with periodontitis susceptibility.Oral Dis. 2015 May;21(4):443-50. doi: 10.1111/odi.12297. Epub 2014 Dec 19. Oral Dis. 2015. PMID: 25385297
-
Association between TGF-β1 Polymorphisms and Head and Neck Cancer Risk: A Meta-Analysis.Front Genet. 2017 Nov 3;8:169. doi: 10.3389/fgene.2017.00169. eCollection 2017. Front Genet. 2017. PMID: 29163637 Free PMC article.
-
Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.Int J Clin Exp Med. 2015 May 15;8(5):6638-49. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221201 Free PMC article. Review.
-
Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis.J BUON. 2015 May-Jun;20(3):829-41. J BUON. 2015. PMID: 26214637 Review.
Cited by
-
Cytokine (IL-10, IL-6, TNF-α and TGF-β1) Gene Polymorphisms in Chronic Hepatitis C Virus Infection among Malay Male Drug Abusers.Biomedicines. 2021 Aug 30;9(9):1115. doi: 10.3390/biomedicines9091115. Biomedicines. 2021. PMID: 34572300 Free PMC article.
-
Association of TGF-ß1 polymorphisms and chronic hepatitis C infection: a Meta-analysis.BMC Infect Dis. 2019 Aug 30;19(1):758. doi: 10.1186/s12879-019-4390-8. BMC Infect Dis. 2019. PMID: 31470810 Free PMC article.
-
TGF-β1 polymorphisms -509 C>T and +915 G>C and risk of pancreatic cancer.Gastroenterol Hepatol Bed Bench. 2017 Winter;10(1):14-20. Gastroenterol Hepatol Bed Bench. 2017. PMID: 28496942 Free PMC article.
-
TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3317-3326. doi: 10.31557/APJCP.2021.22.10.3317. Asian Pac J Cancer Prev. 2021. PMID: 34711009 Free PMC article.
References
-
- Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29(Suppl 1):74–81. - PubMed
-
- Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41–52. - PubMed
-
- Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol. 2000;32(Suppl 1):98–112. - PubMed
-
- Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006;25:455–471. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous